Activez les alertes d’offres d’emploi par e-mail !
Mulipliez les invitations à des entretiens
Créez un CV sur mesure et personnalisé en fonction du poste pour multiplier vos chances.
An innovative research opportunity awaits a PhD candidate in the vibrant city of Paris, focusing on integrating multiscale models in pharmacology. This role is pivotal in creating digital twins for personalized medicine, allowing for the exploration of treatment strategies tailored to individual patients. The position offers a collaborative environment with leading experts, where you'll engage in cutting-edge research, publish findings, and present at conferences. Enjoy a flexible work schedule, generous leave, and reimbursement for public transport costs, making this a compelling opportunity for aspiring researchers in the field.
Social network you want to login/join with:
col-narrow-left
INRIA
Paris, France
Other
-
Yes
col-narrow-right
d217c6e6c840
1
03.05.2025
17.06.2025
col-wide
The PhD will be funded by the Governmental Acceleration Funding - PEPR Santé Numérique. The candidate will work with all partners of the PEPR DIGPHAT project.
Context:
Pharmacology inherently requires modelling mechanisms across various scales: molecular (identifying drug action mechanisms), cellular (e.g., characterizing tissue lesions and biomarkers), and patient (pharmacokinetics/pharmacodynamics population variability). Notably, all these models are fundamentally longitudinal. Integrating these multiple scales is crucial to individualize treatments, including drug selection, optimal dosage, and associated regimens.
Despite the development of mechanistic models (such as those utilizing differential equations) at each scale by different research communities, there is still a lack of interoperability. Combining all relevant meta-models (each representing its own scale) will create a comprehensive digital pharmacology twin.
Objectives:
To propose a general pathway towards pharmacological digital twins by integrating several multiscale and longitudinal meta-models. Digital twins that enable the a priori investigation of a treatment strategy and the dynamic assessment of the probability of success based on a patient’s longitudinal features.
Main activities:
Additional activities:
Advantages: